The biotech sector is reviving, with IPOs reappearing and BioAge Labs' weight loss drug, Azelaprag, showing market potential.Biotech stocks are volatile, facing challenges like regulatory hurdles and ...
Source LinkThe biotech sector is reviving, with IPOs reappearing and BioAge Labs' weight loss drug, Azelaprag, showing market potential.Biotech stocks are volatile, facing challenges like regulatory hurdles and ...
Source Link
Comments